Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes
Grace Ward(University of South Florida), Alan F. List(Precision BioSciences (United States))
Cited by 38
Related Papers
Efficacy of Lenalidomide in Myelodysplastic Syndromes
|New England Journal of Medicine|2005|874
<i>TP53</i> suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients
|Proceedings of the National Academy of Sciences|2013|53
Erythropoietin Receptor Signaling Is Membrane Raft Dependent
|PLoS ONE|2012|32